Seminars in Radiation Oncology
Volume 17, Issue 4 , Pages 293-297 , October 2007

Advanced Technologies in Image-Guided Radiation Therapy

  • James M. Balter, PhD

      Affiliations

    • Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
    • Corresponding Author InformationAddress reprint requests to James M. Balter, PhD, Radiation Oncology Dept., University of Michigan, 1500 E. Medical Center Dr, Box 0010, Ann Arbor, MI 48109-0030.
    • ,
  • Yue Cao, PhD

      Affiliations

    • Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
    • Department of Radiology, University of Michigan, Ann Arbor, MI.

References 

  1. Shirato H, Shimizu S, Kitamura K, et al. Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. Int J Radiat Oncol Biol Phys. 2000;48:435–442
  2. Shirato H, Oita M, Fujita K, et al. Feasibility of synchronization of real-time tumor-tracking radiotherapy and intensity-modulated radiotherapy from viewpoint of excessive dose from fluoroscopy. Int J Radiat Oncol Biol Phys. 2004;60:335–341
  3. Murphy M, Balter J, Balter S, et al. The management of imaging dose during image-guided radiotherapy: Report of AAPM therapy task group. 2006;75
  4. Chen SC, Carton AK, Albert M, et al. Initial clinical experience with contrast-enhanced digital breast tomosynthesis. Acad Radiol. 2007;14:229–238
  5. Niklason LT, Christian BT, Niklason LE, et al. Digital tomosynthesis in breast imaging. Radiology. 1997;205:399–406
  6. Smith A. Full-field breast tomosynthesis. Radiol Manage. 2005;27:25–31
  7. Van Ongeval C, Bosmans H, Van Steen A. Current status of digital mammography for screening and diagnosis of breast cancer. Curr Opin Oncol. 2006;18:547–554
  8. Godfrey DJ, Yin FF, Oldham M, et al. Digital tomosynthesis with an on-board kilovoltage imaging device. Int J Radiat Oncol Biol Phys. 2006;65:8–15
  9. Seiler PG, Blattmann H, Kirsch S, et al. A novel tracking technique for the continuous precise measurement of tumour positions in conformal radiotherapy. Phys Med Biol. 2000;45:N103–N110
  10. Balter JM, Wright JN, Newell LJ, et al. Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:933–937
  11. Willoughby TR, Kupelian PA, Pouliot J, et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;65:528–534
  12. Kupelian P, Willoughby T, Mahadevan A, et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1088–1098
  13. Barnes AS, Haker SJ, Mulkern RV, et al. Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. Urology. 2005;66:1319
  14. Haker SJ, Mulkern RV, Roebuck JR, et al. Magnetic resonance-guided prostate interventions. Top Magn Reson Imaging. 2005;16:355–368
  15. Pickett B, Vigneault E, Kurhanewicz J, et al. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys. 1999;44:921–929
  16. Chen L, Price RA, Wang L, et al. MRI-based treatment planning for radiotherapy: Dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys. 2004;60:636–647
  17. Mizowaki T, Nagata Y, Okajima K, et al. Development of an MR simulator: Eexperimental verification of geometric distortion and clinical application. Radiology. 1996;199:855–860
  18. Cao KJ, Xie CM, Huang PY, et al. Application of magnetic resonance imaging to clinical classification of nasopharyngeal carcinoma. Ai Zheng. 2007;26:164–167
  19. Cao Y, Nagesh V, Hamstra D, et al. The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res. 2006;66:8912–8917
  20. Cao Y, Shen Z, Chenevert TL, et al. Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI. J Magn Reson Imaging. 2006;24:288–296
  21. Cao Y, Sundgren PC, Tsien CI, et al. Physiologic and metabolic magnetic resonance imaging in gliomas. J Clin Oncol. 2006;24:1228–1235
  22. Tsien C, Gomez-Hassan D, Chenevert TL, et al. Predicting outcome of patients with high-grade gliomas after radiotherapy using quantitative analysis of T1-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2007;67:1476–1483
  23. Hamstra DA, Chenevert TL, Moffat BA, et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A. 2005;102:16759–16764
  24. Cao Y, Tsien CI, Nagesh V, et al. Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys. 2006;64:876–885
  25. Chenevert TL, Meyer CR, Moffat BA, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging. 2002;1:336–343
  26. Nagesh V, Chenevert TL, Tsien CI, et al. Quantitative characterization of hemodynamic properties and vasculature dysfunction of high-grade gliomas. NMR Biomed. 2007;(in press)
  27. Ross BD, Moffat BA, Lawrence TS, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther. 2003;2:581–587
  28. Moller HE, Chen XJ, Saam B, et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med. 2002;47:1029–1051
  29. Yablonskiy DA, Sukstanskii AL, Leawoods JC, et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc Natl Acad Sci U S A. 2002;99:3111–3116
  30. Salerno M, Altes TA, Mugler JP, et al. Hyperpolarized noble gas MR imaging of the lung: potential clinical applications. Eur J Radiol. 2001;40:33–44
  31. Jakob PM, Wang T, Schultz G, et al. Magnetization transfer short inversion time inversion recovery enhanced 1H MRI of the human lung. Magma. 2002;15:10–17
  32. Marks LB, Sherouse GW, Munley MT, et al. Incorporation of functional status into dose-volume analysis. Med Phys. 1999;26:196–199
  33. Raaymakers BW, Raaijmakers AJ, Kotte AN, et al. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: Dose deposition in a transverse magnetic field. Phys Med Biol. 2004;49:4109–4118
  34. Raaijmakers AJ, Raaymakers BW, van der Meer S, et al. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: impact of the surface orientation on the entrance and exit dose due to the transverse magnetic field. Phys Med Biol. 2007;52:929–939

PII: S1053-4296(07)00056-2

doi: 10.1016/j.semradonc.2007.06.001

Seminars in Radiation Oncology
Volume 17, Issue 4 , Pages 293-297 , October 2007

Article Tools

* Image Usage & Resolution